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doi:10.1016/j.pedneo.2011.03.004Background: Renal calcification in preterm infants has been described frequently. The etio-
logic factors have not yet been fully clarified. The objective of this study was to evaluate
the incidence of and risk factors for renal calcification in our population.
Methods: We retrospectively reviewed the charts of very low birth weight preterm infants
during a 1-year period. Renal ultrasound scans were performed at term or before discharge
and at a corrected age of 1 year.
Results: Six infants (6%) had renal calcification at term or before discharge compared with 96
who did not. Factors significantly associated with renal calcification included gestational age
(26 weeks vs. 29 weeks, pZ 0.006), birth weight (851 g vs. 1141 g, pZ 0.004), duration of
mechanical ventilation (69 days vs. 29 days, pZ 0.002), length of intensive care (72 days vs.
41 days, pZ 0.013), furosemide therapy (33% vs. 3%, pZ 0.027), and dexamethasone therapy
(50% vs. 2% pZ 0.001). Birth weight and dexamethasone therapy had significant independent
association after stepwise logistic regression analysis. Sex, oliguria, acidosis, duration of
oxygen therapy, length of hospital stay, nutrition status, and nephrotoxic drugs did not differ
between the two groups. Three of the six infants had spontaneous remission of renal calcifica-
tion, whereas two patients without the finding in neonatal stage had renal calcification at
a corrected age of 1 year.
Conclusion: The incidence of renal calcification in very low birth weight infants in this study
was relatively low, and the calcification was transient in one-half of the infants. Extremely
premature, sick infants requiring long-term ventilation, and those receiving furosemide orof Pediatrics, Hsinchu Mackay Memorial Hospital, No. 690, Section 2, Guangfu Road, Hsinchu City,
org.tw (H.-Y. Chang).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
146 H.-Y. Chang et aldexamethasone were more likely to have renal calcification. Clinicians should be aware that
renal calcification may develop beyond the neonatal stage.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Renal calcification, including nephrocalcinosis and neph-
rolithiasis, is well recognized in adults but is also increas-
ingly seen in preterm infants. Since first reported in 1982 by
Hufnagle et al,1 nephrocalcinosis has been thought by
a number of investigators to be a complication of prematu-
rity, very low birth weight (VLBW) infants being particularly
vulnerable.2e9 The reported incidence has ranged from 10%
to 65%, depending on the study population, screening
criteria, and ultrasound equipment used.2e9 The etiology of
renal calcification has not yet been fully clarified, but
a multifactorial origin is likely.10 Furosemide therapy has
been proposed as a risk factor because of its hypercalciuric
effect.11,12 Other factors, such as low gestational age; low
birth weight; prolonged oxygen dependency; imbalance in
urine or serum chemistry; and treatment with corticoste-
roids, xanthines, and nephrotoxic drugs, may also contribute
to renal calcification.2e14 A small study from the United
States found that white infants were more likely than non-
whites to have nephrocalcinosis,15 suggesting there may be
ethnic differences. There is also debate about the prognosis
of nephrocalcinosis, as both spontaneous resolution without
sequelae and ongoing renal tubular dysfunction have been
reported.16e20 The objective of this retrospective study was
to evaluate the incidence and risk factors of renal calcifi-
cation in our population of VLBW infants over the course of
1 year. As far as we are aware, this is the first study of renal
calcification in premature Taiwanese infants.
2. Materials and Methods
We retrospectively reviewed the charts of all premature
infants with a birth weight below 1500 g and a gestational
age of less than 34 weeks who were hospitalized in the
neonatal intensive care unit (NICU) of Taipei Mackay
Memorial Hospital from July 2007 to June 2008. Patients
who died before discharge or had major congenital mal-
formations were excluded, as were infants who were not
born at our hospital or who did not have renal ultrasonog-
raphy during hospitalization. This study was approved by
the ethics and medical research committees in our hospital.
Based on a clinical impression that renal calcification
was relatively common among premature infants, in July
2007, we established the practice of performing routine
renal ultrasound scans at term or before discharge in all
VLBW preterm infants. The diagnosis of renal calcification
included nephrocalcinosis and nephrolithiasis, using criteria
described by Myracle et al.21 Nephrocalcinosis was defined
as focal areas of hyperechogenicity within the renal cortex,
and nephrolithiasis was defined as calculus located in the
collecting system. Patients were examined in the supine
and prone positions. All scans were performed by one
experienced nephrologist using ALOKA SSD-1700 equipmentwith a 5 MHz transducer (Aloka Co. Ltd., Wallingford,
Conn., USA), and all scan photographs were reviewed by
another nephrologist. If renal calcification was detected,
renal ultrasound was performed monthly until resolution.
All infants had a follow-up scan at a corrected age of 1 year,
regardless of whether calcification had been noted on the
initial scan.
For this study, a number of variables were compared
between infants with and without renal calcification.
Demographic characteristics assessments included gesta-
tional age, birth weight, Apgar score, and gender. Oliguria
was definedas urine output of less than 1 mL/kg/d in 24 hours
and acidosis as an arterial blood pH less than 7.2. All infants
were fed with either the mother’s milk or preterm infant
formula. When oral alimentation reached 100 mL/kg, human
milk fortifier was added. Most infants received parenteral
nutrition before full feeding was established. The number of
days of parenteral nutrition, formula feeding, and breast-
feeding were recorded. Infants who required oxygen support
at a postconceptional age of 36 weeks and who had chest
X-ray changes were defined as having chronic lung disease
(CLD). The duration of mechanical ventilation, oxygen
therapy, and length of NICU and hospital stay were recorded,
as were all medications with dosage and duration of use.
If renal calcification was detected, blood and spot urine
samples were taken and assayed by standard laboratory
methods. Serum chemistry studies included calcium, phos-
phate, and creatinine. Random urine specimens were
collected in attached plastic bags and routine urinalysis
performed and calcium, phosphate, and creatinine levels
measured. The urinary calcium to creatinine ratio was
calculated; a value higher than 0.8 mg/mg was counted as
hypercalciuria.22
For statistical analysis, Fisher’s exact test was used for
nominal parameters and t test was used for continuous
parameters. A p value less than 0.05 was considered
statistically significant. Regarding the correlation of all
parameters, Pearson’s correlation coefficient was used for
comparing two continuous parameters. Eta-squared corre-
lation ratio was used for nominal by continuous parameters
and lambda coefficient was used for nominal by nominal
parameters. Stepwise forward Wald method was used in the
multivariate logistic regression to select independent vari-
ables. The parameters entry and removal criteria was
p value less than 0.05 and more than 0.10, respectively. All
of the statistical calculations were performed using the SPSS
17th edition for Windows XP (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Neonatal stage
During the 1-year study period, 121 surviving VLBW infants
with a gestational ageof less than34weekswerehospitalized
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and 45 girls) whose charts were reviewed. Renal calcification
was detected in only six neonates (6%) at term or before
discharge (Table 1). Those with renal calcification had
significantly lower gestational age and smaller birth weight
than those without (Table 2). Four of the six weighed less
than 1000 g or were born at less than 28 weeks.
All babies with renal calcification were asymptomatic;
none had microscopic hematuria. Renal calcification
affected boys and girls equally. There were no significant
differences between those with and without renal calcifi-
cation in delivery mode, Apgar score, hypotension, oliguria,
size of kidney, requirement for parenteral nutrition, or type
of feeding. The incidence of respiratory distress syndrome
and CLD did not differ significantly between the two
groups. The total days of oxygen therapy did not differ, but
the babies with renal calcification had a significantly longer
duration of mechanical ventilation and NICU stay. The
length of hospital stay, however, did not differ (Table 2).
The use of surfactant, calcium gluconate, and
aminophylline neither differed between the two groups nor
was there any association between renal calcification and
nephrotoxic drugs, such as gentamicin, vancomycin,
amphotericin B, or indomethacin. Infants with renal calci-
fication were significantly more likely to have received
regular furosemide or postnatal dexamethasone therapy for
CLD than were the unaffected infants (Table 2).
As to the correlation of continuous parameters, not only
there was a multicollinearity between these variables but
also possible interaction effect among them. Multivariate
logistic regression was used to create the best statistical
model relating to renal calcification in VLBW infants. The
factors that had significant independent associations with
renal calcification after the stepwise procedure were birth
weight and dexamethasone therapy. Other factors were
excluded, and this may have been caused by multi-
collinearity among independent variables. However, we
still considered the results of the Fisher’s exact test and t
test showed its statistical significance.
In the renal calcification group, serum chemistry studies,
urinalysis, andurinecalciumwereallwithinnormal limits.The
mean urinary calcium to creatinine ratio was 1.3 0.9 mg/
mg, and three of the infants had hypercalciuria.
3.2. Follow-up
On follow-up renal ultrasound examinations, three of the
infants with nephrocalcinosis had spontaneous resolution ofTable 1 Six very low birth weight infants with renal calcificatio
Patient
number
Gestational
age (wk)
Birth
weight (g)
Age at
diagnosis (d)
Site Ne
1 25 668 105 Bilateral 
2 25 670 72 Right þ
3 29 1003 48 Bilateral 
4 26 804 92 Bilateral 
5 28 1188 73 Bilateral 
6 24 770 93 Bilateral þ
CLDZ chronic lung disease.the calcification between 1 and 2 months after diagnosis.
Two had nephrolithiasis, and one patient had persistent
nephrocalcinosis.
A record of the follow-up ultrasound at a corrected age
of 1 year was available for 67 babies, excluding 4 who died
and 31 lost to follow-up. Renal calcification had developed
in two who did not have it neonatally. One had neph-
rolithiasis, presenting with recurrent urinary tract infec-
tions and microscopic hematuria; this infant later
underwent surgery to remove the stone. Excluding patients
lost to follow-up, the incidence of renal calcification
increased up to 11% (8/71) at 1 year corrected age.
4. Discussion
The 6% incidence of renal calcification in this series of
VLBW infants was much lower than we had expected based
on previous reports.1e7 There are several possible expla-
nations for this finding. A number of studies reporting a high
incidence of nephrocalcinosis in VLBW neonates were
published in the 1990s. It is possible that advances in
neonatal intensive care since then have reduced the risk.
Earlier reports noted a greater use of furosemide and
corticosteroids than is now common for premature infants
with CLD.1,2,11e13 As far as we are aware, this is the first
series from Taiwan of VLBW premature infants with renal
calcification. It is possible that the incidence varies with
ethnicity, as has been suggested elsewhere.15
The number of patients with renal calcification in our
study was relatively small, however, it was quite striking
that four of our six patients with renal calcification weighed
less than 1000 g at birth and were delivered at a gestational
age of less than 28 weeks. This finding is in agreement with
several other studies2,3,7,18 and suggests that extreme
immaturity of the kidneys is an important risk factor.
It is also important to consider differences in screening
schedules and techniques that might influence the reported
incidence of nephrocalcinosis.2e9 For example, we used
a 5-MHz transducer, whereas Campfield et al23 suggested
that a 7.5-MHz transducer might reduce interobserver
variability. Other conditions may also cause transient
increased renal medullary echogenecity before 2 weeks of
life in neonates,8,24 including Tamm-Hofsfall proteins,
candidiasis, cytomegalovirus infection, cortical necrosis, or
renal vein thrombosis.24 Renal ultrasound screening in early
life may overestimate this hyperechogenecity as renal
calcification. The cost of screening could be reduced by
limiting it to infants with those risk factors, for example, ton on renal ultrasonography
phrolithiasis Spontaneous
resolution
CLD and medications
þ þ, furosemide, dexamethasone
 þ, dexamethasone
þ 
þ þ
 
 þ, furosemide, dexamethasone
Table 2 Comparison of very low birth weight infants with and without renal calcification
Characteristics With (nZ 6) Without (nZ 96) p
Gestational age (wk)* (mean SD) 26.2 2.0 29.0 2.4 0.006
Birth weight (g)* (mean SD) 851 206 1141 238 0.004
Chronic lung disease [n, (%)] 4 (67) 40 (42) 0.219
Mechanical ventilation (d)* (mean SD) 69.5 44.6 28.5 29.4 0.002
Oxygen therapy (d) (mean SD) 84.5 43.7 57.3 67.0 0.330
NICU stay (d)* (mean SD) 72.2 39.7 41.1 28.4 0.013
Hospitalization (d) (mean SD) 94.2 33.8 73.9 37.0 0.194
Furosemide [n, (%)]* 2 (33) 3 (3) 0.027
Dexamethasone [n, (%)]* 3 (50) 2 (2) 0.001
* A p value <0.05.
NICUZ neonatal intensive care unit; SDZ Standard deviation.
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age of less than 28 weeks. Asymptomatic infants might be
screened only at discharge.
Nutritional factors that may contribute to renal calcifi-
cation include a relative phosphorus deficiency in breast-
fed infants of the effects of parenteral nutrition,5,6,14 but
we did not find such an association. Prolonged mechanical
ventilation has been reported as a risk factor for neph-
rocalcinosis,3,7 and we did find this association in our study.
A possible reason for this is decreased excretion of urinary
citrate in preterm infants with lung disease. However,
despite the longer duration of mechanical ventilation in our
infants with renal calcification, we did not detect a statis-
tically significant association with respiratory distress
syndrome or CLD. The longer NICU stay suggests that sicker
infants are more likely to have renal calcification, so such
infants should bear more careful monitoring.
Several authors have stated that elevated urinary
calcium excretion is a main factor in the pathogenesis of
nephrocalcinosis,2,6,9,11 although urinary citrate, uric acid,
and oxalate excretion may also play a role in the patho-
genesis of renal calcifications.6,10,25e28 Although data on
normal urinary calcium excretion in preterm infants are
limited, hypercalciuria is reportedly very common in
preterm infants; it likely has a multifactorial etiology.3,8,10
Although prolonged furosemide and dexamethasone seem
to increase the risk, xanthine and calcium gluconate with
their hypercalciuric effects were not associated with renal
calcification in our study. There was also no direct relation
between renal calcification and nephrotoxic drugs.
We confirmed the observation that renal calcifications
may resolve spontaneously.16e18 Although the long-term
effect on renal function in these patients is debated,16e20
a neonate with renal calcification should certainly be fol-
lowed for other possible complications, including hema-
turia, urinary tract infection, obstruction, and
nephrolithiasis. None of our patients with renal calcifica-
tion had urinary tract infection or hematuria. However, of
the two without neonatal abnormalities at neonatal stage
who were found to have renal calcifications at a corrected
age of 1 year, one had recurrent hematuria and urinary
tract infections. The number of patients who developed
renal calcification beyond neonatal stage may be under-
estimated because some of them may have had calcifica-
tion and resolved spontaneously before 1 year of age. Thequestion of etiology in these infants is unclear; it is
impossible to know whether their prematurity played a role
in their subsequent renal calcification.
Among the limitations of this study is that it was
a retrospective experience in a single medical center and
lacked long-term renal function follow-up. Data on
biochemical studies was limited to what was clinically
indicated, limiting comparisons between the two groups.
Because the number of infants with renal calcification was
relatively small in our study, further prospective studies are
required to confirm the incidence and the role of risk
factors in neonatal renal calcification in modern medical
era.
We conclude that despite the low incidence of neonatal
renal calcification in our series, several factors stand out
that are consistent with other studies. The risk of renal
calcification in VLBW preterm infants is higher in smaller,
sicker, less mature infants, especially those requiring long-
term ventilation or treatment with dexamethasone or
furosemide. It is reassuring to know that neonatal renal
calcification may resolve spontaneously. Clinicians should
be alert to renal calcification developing beyond the
neonatal stage, with rigorous evaluation of any signs or
symptoms suggestive of it.Acknowledgments
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